| Product NDC: | 29336-815 |
| Proprietary Name: | Maxair Autohaler |
| Non Proprietary Name: | pirbuterol acetate |
| Active Ingredient(s): | 200 ug/1 & nbsp; pirbuterol acetate |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | INHALANT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 29336-815 |
| Labeler Name: | Graceway Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020014 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080101 |
| Package NDC: | 29336-815-21 |
| Package Description: | 400 INHALANT in 1 INHALER (29336-815-21) |
| NDC Code | 29336-815-21 |
| Proprietary Name | Maxair Autohaler |
| Package Description | 400 INHALANT in 1 INHALER (29336-815-21) |
| Product NDC | 29336-815 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pirbuterol acetate |
| Dosage Form Name | INHALANT |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 20080101 |
| Marketing Category Name | NDA |
| Labeler Name | Graceway Pharmaceuticals, LLC |
| Substance Name | PIRBUTEROL ACETATE |
| Strength Number | 200 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |